Association between serum fibroblast growth factor 21 and diabetic nephropathy

Wei-Xia Jian1, Wen-Hui Peng, Jie Jin

  • 1Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.

Insights

Fibroblast growth factor 21 (FGF-21) is linked to diabetic nephropathy. Higher FGF-21 levels correlate with increased urinary albumin excretion in type 2 diabetes patients, suggesting its involvement in kidney damage.

Area of Science:

  • Endocrinology and Metabolism
  • Nephrology
  • Biochemistry

Background:

  • Fibroblast growth factor 21 (FGF-21) is recognized as a metabolic regulator with demonstrated benefits in animal models of diabetes.
  • Diabetic nephropathy is a significant complication of diabetes mellitus, characterized by kidney damage and albuminuria.

Purpose of the Study:

  • To investigate the association between serum FGF-21 levels and diabetic nephropathy in human subjects.
  • To determine if FGF-21 is independently correlated with urinary albumin excretion (UAE) in patients with type 2 diabetes mellitus (T2DM).

Main Methods:

  • Serum FGF-21 levels were measured using enzyme-linked immunosorbent assay (ELISA) in control subjects and T2DM patients across different stages of albuminuria (normoalbuminuria, microalbuminuria, macroalbuminuria).
  • Multiple linear regression models were employed to analyze the relationship between FGF-21, other biomedical indices, and UAE, adjusting for potential confounders.

Main Results:

  • Median serum FGF-21 levels were significantly elevated in T2DM patients compared to controls.
  • Serum FGF-21 levels showed a positive correlation with the severity of albuminuria, being highest in the macroalbuminuria group.
  • FGF-21, fasting plasma glucose, and high-density lipoprotein cholesterol were independently associated with UAE in T2DM patients after confounder adjustment.

Conclusions:

  • Circulating FGF-21 levels are independently correlated with urinary albumin excretion in type 2 diabetes mellitus patients.
  • These findings suggest that FGF-21 may play a role in the pathogenesis of diabetic nephropathy.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...